Jim Cramer's Hottest GLP-1 and Weight Loss Stock Picks
In this article, we will discuss: Jim Cramer's Hottest GLP-1 and Weight Loss Stock Picks. For more stocks, you can head to Jim Cramer's Hottest GLP-1 and Weight Loss Stock Picks: Top 5 Stocks.
Terns Pharmaceuticals Inc. (TERN)
This company is not actively trading or the ticker does belong to another company in our database now.
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | HBK Investments David Costen Haley | 0 | $0 | 0% | |
| 2. | Citadel Investment Group Ken Griffin | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | ||
| 4. | 0 | $0 | 0% | ||
| 5. | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.93 | 5,000 | $19,649.50 | 25,000 | 2025-06-27 | Filing | |
| $3.93 | 5,000 | $19,633.50 | 20,000 | 2025-06-27 | Filing | |
| $3.87 | 23,314 | $90,229.84 | 47,083 | 2025-06-25 | Filing | |
| $3.95 | 5,000 | $19,732.50 | 15,000 | 2025-06-16 | Filing | |
| $3.72 | 5,000 | $18,600.00 | 10,000 | 2025-06-13 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $52.75 | 942 | $49,692.95 | 105,673 | 2026-04-01 | Filing | |
| $47.30 | 2,770 | $131,027.65 | 288,976 | 2026-03-16 | Filing | |
| $46.57 | 11,813 | $550,080.61 | 291,746 | 2026-03-16 | Filing | |
| $39.80 | 4,083 | $162,501.36 | 288,976 | 2026-02-17 | Filing | |
| $39.22 | 8,159 | $319,963.34 | 293,059 | 2026-02-17 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 11,083 | $584,296 | 0% | |
| 2. | 1,424 | $75,401 | 0% | |
| 3. | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
Analyst Optimistic on Terns (TERN) Citing Possible $4.8B Market for Upcoming Leukemia Drug
Terns Pharmaceuticals Inc. (NASDAQ:TERN) is one of 15 stocks with the biggest hedge fund momentum, after gaining 42 hedge fund holders during the fourth quarter of 2025.
15 Stocks with the Biggest Hedge Fund Momentum
In this article, we talk about the 15 stocks with the biggest hedge fund momentum.
Terns Pharmaceuticals (TERN) Eyes Expansion Beyond China Amid Strong Analyst Sentiment
Terns Pharmaceuticals, Inc. (NASDAQ:TERN) is included in our list of the 11 Best Performing Stocks in the Last 12 Months. On January 16, 2026, Terns Pharmaceuticals, Inc.
11 Best Performing Stocks in the Last 12 Months
In this piece, we discuss the 11 Best Performing Stocks in the Last 12 Months.
Wall Street Forecasts 42.31% Upside To Terns Pharmaceuticals, Inc. (TERN)
Terns Pharmaceuticals, Inc. (NASDAQ:TERN) is among the 14 best booming stocks to buy right now.
14 Best Booming Stocks to Buy Right Now
This article looks at the 14 Best Booming Stocks to Buy Right Now.
Citizens Maintains An Outperform Rating On Terns Pharmaceuticals, Inc. (TERN)
Terns Pharmaceuticals, Inc. (NASDAQ:TERN) is among the 20 Best Performing Stocks in 2025. On December 11, 2025, TheFly reported that Citizens boosted its price goal for Terns Pharmaceuticals, Inc.
20 Best Performing Stocks in 2025
In this article, we will discuss: 20 Best Performing Stocks in 2025. Reuters reported on January 1, 2026, that U.S.
Tern Pharmaceuticals (TERN) Soars 630% on CML Treatment Best-in-Class Potential
We recently published 10 Market Stars Behind Millionaire-Making in 2025. Terns Pharmaceuticals, Inc. (NASDAQ:TERN) is one of the top performers.
Hedge Fund Resource Center